SS Innovations Achieves Milestone with First Robotic Telesurgery

Tip Ranks
2025.09.09 12:59
portai
I'm PortAI, I can summarize articles.

SS Innovations International (SSII) announced the successful completion of its first robotic telesurgery using the MantraM mobile unit on September 9, 2025. Conducted by Dr. Priya Bhave Chittawar, the complex hysterectomy was performed remotely in Bhopal, India. The company aims to provide advanced surgical care to underserved populations. Analyst ratings for SSII stock are mixed, with a Hold rating and a $6.00 price target, while Spark's AI Analyst rates it as Neutral due to strong corporate events but concerns over financial performance and valuation metrics.

SS Innovations International ( (SSII) ) just unveiled an update.

On September 9, 2025, SS Innovations International announced the successful completion of the first robotic telesurgery performed from its MantraM mobile robotic telesurgery unit. This milestone, achieved by Dr. Priya Bhave Chittawar, involved a complex hysterectomy conducted remotely in Bhopal, India, highlighting the company’s mission to provide advanced surgical care to underserved populations. The MantraM bus tour, launched in July 2025 across India, aims to demonstrate the capabilities of SS Innovations’ mobile unit and SSi Mantra system, focusing on hospitals and medical institutions in underserved communities.

The most recent analyst rating on (SSII) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.

Spark’s Take on SSII Stock

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

SS Innovations International’s score is primarily driven by its strong corporate events, which highlight significant achievements and growth potential. However, financial performance issues, particularly in profitability and cash flow, along with a bearish technical outlook and poor valuation metrics, weigh heavily on the overall score.

To see Spark’s full report on SSII stock, click here.

More about SS Innovations International

SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. Their product range includes the proprietary ‘SSi Mantra’ surgical robotic system and ‘SSi Mudra’ surgical instruments, supporting various procedures including robotic cardiac surgery. The company, headquartered in India, plans to expand its global presence with its advanced, user-friendly, and cost-effective solutions.

Average Trading Volume: 227,017

Technical Sentiment Signal: Sell

Current Market Cap: $1.36B

For a thorough assessment of SSII stock, go to TipRanks’ Stock Analysis page.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.